In a recent study researchers have examined the efficacy and safety of bimekizumab, a monoclonal antibody that selectively inhibits IL-17A and IL-17F, in patients with active psoriatic arthritis who have not previously undergone biologic...
In a recent study researchers have examined the efficacy and safety of bimekizumab, a monoclonal antibody that selectively inhibits IL-17A and IL-17F, in patients with active psoriatic arthritis who have not previously undergone biologic...
Researchers aimed to systematically explore factors influencing the choice of a new once-daily oral psoriasis treatment among US adults with moderate to severe psoriasis.
Researchers aimed to systematically explore factors influencing the choice of a new once-daily oral psoriasis treatment among US adults with moderate to severe psoriasis.
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.